The network approach to psychopathology has recently received considerable attention, and is as a novel way of conceptualizing mental disorders as causally interacting symptoms. In this study, we modeled a joint network of depression symptoms and depression-related brain structures, using 21 symptoms and five regional brain measures. We used a mixed sample of 268 individuals previously treated for one or more major depressive episodes and never depressed individuals. The network revealed associations between brain structure and unique depressive symptoms, which may clarify relationships regarding symptomatic and biological heterogeneity in depression.
Introduction
Various patterns of structural brain abnormalities have been associated with depression, yet sensitive, specific and clinically predictive brain correlates have proven to be difficult to characterize [1] . The currently best available empirical evidence on neuroanatomical differences between patients with major depression (MDD) and healthy controls are two meta-analyses of approximately 10.000 individuals [2, 3] . These reports show widespread alterations in cortical regions and in hippocampal volume, but no associations between depression severity and brain structure. Inconsistencies in the neuroimaging literature may be explained by the fact that depression is highly heterogeneous, featuring over 50 symptoms [4] , where symptom constellations may reflect different phenomena with distinct underlying biological causes [1] .
Understanding the neural substrates of specific symptoms may provide important information about mechanisms underlying depression vulnerability. A growing body of research under the umbrella term 'network approach' has recently received considerable attention [5] ; the approach understands and aims to model mental disorders as systems of causally interacting symptoms. So far, network studies have solely been based on symptoms, ignoring relevant neurobiological factors [6] . Here, we address this knowledge gap by modelling a joint network of depression-related brain structures and individual depression symptoms, using 21 symptoms and five regional brain measures. The sample is a mixed group of individuals that previously has been treated for one or more major depressive episodes (MDE), and never depressed individuals, with the goal to model a continuum of depression severity.
Methods
Depression symptoms were measured using the Beck Depression Inventory (BDI-II). Wholebrain volumetric segmentation and cortical surface reconstruction of MRI images were performed with FreeSurfer 5.3 (https://surfer.nmr.mgh.harvard.edu/). Five regional brain measures were selected based on the MDD case-control differences showing the largest bilateral effects in the studies from the ENIGMA MMD working group [2, 3] 
Results
The symptom-brain network is depicted in Figure 1 . All brain structures were positively interconnected, with regularized partial correlations up to 0.41, see Table 1 . Insula was negatively associated with loss of interest in sex and sadness. Hippocampus was negatively associated with sadness and changes in appetite, and a positively associated with loss of interest.
Cingulate had a negative association with sadness, while fusiform gyrus had weak but positive associations with self-criticism and crying. Table 1 Sparse partial correlations between brain structure measures, and between brain structure measures and depressive symptoms in the network model.
Discussion
Here we establish the first link between individual depression symptoms and neuroanatomy using symptom network analysis. Our results broadly align with prior literature showing that depression symptoms differentially relate to important outcomes such as impairment and risk factors, and demonstrate the importance of studying specific features of depression over one heterogeneous category [5, 6] . The associations between symptoms and brain structure may reflect the heterogeneous nature of the disorder, and may offer important cues about underlying neural mechanisms in MDD. The results await replication in larger samples and other patient groups. In this study depression history was assessed retrospectively and previous MDE was classified independent of type of treatment, combination treatment, treatment response or time since the last episode. We hope the reported results can pave the way for future studies integrating neurobiological measures in network analyses, which represent a step towards validation of biomarkers.
